PatientsVille.com LogoDapagliflozin Side Effects

How can Dapagliflozin Side Effects affect You? | PatientsVille.com

View and Submit Dapagliflozin Side Effects

Your Dapagliflozin Side Effect submission can play a very important role. Reporting your experience could help identify an unknown risk and inform other patients and health care professionals.

>>Compare Dapagliflozin side effects | View FDA-reported Dapagliflozin side effects

Dapagliflozin Side Effects and Adverse Effects reported to US Food and Drug Administration (FDA)

Spread the word: Share, Email, Print

Nephrolithiasis (7752939-7)
on Aug 23, 2011 Male from UNITED STATES , 55 years of age, was diagnosed with
  • type 2 diabetes mellitus
  • hyperuricaemia
and was treated with Dapagliflozin. Directly after, patient experienced the unwanted or unexpected Dapagliflozin side effects: nephrolithiasis. Dapagliflozin dosage: N/A.
Associated medications used:
  • Allopurinol
  • Metformin Hcl
Patient was hospitalized.

Dehydration, Gastrointestinal Disorder, Nausea, Renal Failure Acute (7204431-6)
Patient was taking Dapagliflozin. Patient felt the following Dapagliflozin side effects: dehydration, gastrointestinal disorder, nausea, renal failure acute on Dec 20, 2010 from AUSTRALIA Additional patient health information: Male , 67 years of age, was diagnosed with
  • type 2 diabetes mellitus
and. Dapagliflozin dosage: N/A. Patient was hospitalized.

Benign Prostatic Hyperplasia, Blood Creatine Phosphokinase Increased, Calculus Bladder, Glomerular Filtration Rate Decreased, Haematuria, Urinary Tract Obstruction (7114639-6)
Adverse event was reported on Nov 15, 2010 by a Male taking Dapagliflozin (Dosage: N/A) was diagnosed with
  • type 2 diabetes mellitus
and. Location: UNITED KINGDOM , 69 years of age, weighting 211.6 lb, After Dapagliflozin was administered, patient encountered several Dapagliflozin side effects: benign prostatic hyperplasia, blood creatine phosphokinase increased, calculus bladder, glomerular filtration rate decreased, haematuria, urinary tract obstruction.
Multiple concurrent drugs taken:
  • Glipizide


Renal Failure Acute (7036426-X)
on Sep 28, 2010 Male from AUSTRALIA , 67 years of age, was diagnosed with
  • type 2 diabetes mellitus
and was treated with Dapagliflozin. Directly after, patient experienced the unwanted or unexpected Dapagliflozin side effects: renal failure acute. Dapagliflozin dosage: N/A. Patient was hospitalized.


Anaemia (7006528-2)
on Sep 10, 2010 Female from ARGENTINA , 68 years of age, was diagnosed with
  • type 2 diabetes mellitus
and was treated with Dapagliflozin. Patient felt the following Dapagliflozin side effects: anaemia. Dapagliflozin dosage: N/A.
Multiple prescriptions taken:
  • Glipizide


Calculus Bladder (6887065-2)
Patient was taking Dapagliflozin. After Dapagliflozin was administered, patient encountered several Dapagliflozin side effects: calculus bladder on Jul 19, 2010 from UNITED KINGDOM Additional patient health information: Male , 69 years of age, weighting 211.6 lb, was diagnosed with
  • type 2 diabetes mellitus
and. Dapagliflozin dosage: N/A.
Multiple concurrent drugs taken:
  • Glipizide


Arteriosclerosis Coronary Artery (6790305-1)
Adverse event was reported on Jun 17, 2010 by a Male taking Dapagliflozin (Dosage: N/A) was diagnosed with
  • type 2 diabetes mellitus
and. Location: UNITED STATES , 65 years of age, Directly after, patient experienced the unwanted or unexpected Dapagliflozin side effects: arteriosclerosis coronary artery.
Associated medications used:
  • Metformin Hcl (Previosly Taken From 02apr05-29oct07)
  • Actos (Actos 15;07aug08-15sep08(15mg) Actos 30;16sep08-19oct08(30mg) Actos 45;20oct08-02feb09(45mg))
  • Niaspan
  • Protonix
  • Hctz
  • Flonase
  • Aspirin
Patient was hospitalized.

Hepatic Neoplasm Malignant, Prostate Cancer (6616364-4)
on Feb 24, 2010 Male from ARGENTINA , 60 years of age, was diagnosed with
  • type 2 diabetes mellitus
and was treated with Dapagliflozin. Patient felt the following Dapagliflozin side effects: hepatic neoplasm malignant, prostate cancer. Dapagliflozin dosage: Stop Date:10feb09;resume Date:11feb09..
Multiple prescriptions taken:
  • Glipizide (Stop Date 09feb09;resume Date:11feb09.)
  • Glucophage


Hepatic Neoplasm Malignant, Prostate Cancer (6267564-7)
on Jul 02, 2009 Male from ARGENTINA , 60 years of age, was diagnosed with
  • type 2 diabetes mellitus
and was treated with Dapagliflozin. After Dapagliflozin was administered, patient encountered several Dapagliflozin side effects: hepatic neoplasm malignant, prostate cancer. Dapagliflozin dosage: Stop Date:10feb09;resume Date:11feb09..
Multiple concurrent drugs taken:
  • Glipizide (Stop Date 09feb09;resume Date:11feb09.)
  • Glucophage


Hypoglycaemia, Hypoglycaemic Coma, Loss Of Consciousness (6179759-1)
Patient was taking Dapagliflozin. Directly after, patient experienced the unwanted or unexpected Dapagliflozin side effects: hypoglycaemia, hypoglycaemic coma, loss of consciousness on Apr 23, 2009 from GERMANY Additional patient health information: Female , 57 years of age, was diagnosed with
  • type 2 diabetes mellitus
and. Dapagliflozin dosage: N/A.
Associated medications used:
  • Glipizide
  • Metformin Hcl
  • Vesdil


Cellulitis, Gangrene (6179757-8)
Adverse event was reported on Apr 23, 2009 by a Male taking Dapagliflozin (Dosage: N/A) was diagnosed with
  • type 2 diabetes mellitus
and. Location: UNITED STATES , 59 years of age, Patient felt the following Dapagliflozin side effects: cellulitis, gangrene.
Multiple prescriptions taken:
  • Metformin Hcl
Patient was hospitalized.

Hypoglycaemia (6170516-9)
on Apr 23, 2009 Female from GERMANY , 57 years of age, was diagnosed with
  • type 2 diabetes mellitus
and was treated with Dapagliflozin. After Dapagliflozin was administered, patient encountered several Dapagliflozin side effects: hypoglycaemia. Dapagliflozin dosage: N/A.
Multiple concurrent drugs taken:
  • Glipizide
  • Metformin Hcl


Pneumonia, Pulmonary Tuberculosis (6160605-7)
on Apr 17, 2009 Male from SINGAPORE , 42 years of age, was diagnosed with
  • type 2 diabetes mellitus
and was treated with Dapagliflozin. Directly after, patient experienced the unwanted or unexpected Dapagliflozin side effects: pneumonia, pulmonary tuberculosis. Dapagliflozin dosage: Interrupted On 25feb09.
Associated medications used:
  • Metformin Hcl (Taken As Metformin Xr. Interrupted On 25feb09)
Patient was hospitalized.

Pneumonia, Pulmonary Tuberculosis (6135162-1)
Patient was taking Dapagliflozin. Patient felt the following Dapagliflozin side effects: pneumonia, pulmonary tuberculosis on Mar 18, 2009 from SINGAPORE Additional patient health information: Male , 42 years of age, was diagnosed with
  • type 2 diabetes mellitus
and. Dapagliflozin dosage: Interrupted On 25feb09.
Multiple prescriptions taken:
  • Metformin Hcl (Taken As Metformin Xr. Interrupted On 25feb09)
Patient was hospitalized.

Pneumonia (6113088-7)
Adverse event was reported on Mar 03, 2009 by a Male taking Dapagliflozin (Dosage: Interrupted On 25feb09) was diagnosed with
  • type 2 diabetes mellitus
and. Location: SINGAPORE , 42 years of age, After Dapagliflozin was administered, patient encountered several Dapagliflozin side effects: pneumonia.
Multiple concurrent drugs taken:
  • Metformin Hcl (Taken As Metformin Xr. Interrupted On 25feb09)
Patient was hospitalized.

Hypoglycaemia (6085785-3)
on Feb 09, 2009 Female from CANADA , 59 years of age, was diagnosed with
  • type 2 diabetes mellitus
and was treated with Dapagliflozin. Directly after, patient experienced the unwanted or unexpected Dapagliflozin side effects: hypoglycaemia. Dapagliflozin dosage: N/A.
Associated medications used:
  • Novolin 40/60 (Regimin:biphasic)


Creatinine Renal Clearance Decreased (6041884-3)
on Jan 06, 2009 Male from ARGENTINA , 65 years of age, was diagnosed with
  • type 2 diabetes mellitus
and was treated with Dapagliflozin. Patient felt the following Dapagliflozin side effects: creatinine renal clearance decreased. Dapagliflozin dosage: 2.5 Mg Daily From 04-sep-2008; 5 Mg Daily From 25-sep-2008.

Creatinine Renal Clearance Decreased (6026441-7)
Patient was taking Dapagliflozin. After Dapagliflozin was administered, patient encountered several Dapagliflozin side effects: creatinine renal clearance decreased on Dec 23, 2008 from ARGENTINA Additional patient health information: Male , 65 years of age, was diagnosed with
  • type 2 diabetes mellitus
and. Dapagliflozin dosage: 2.5 Mg Daily From 04-sep-2008; 5 Mg Daily From 25-sep-2008.

Ventricular Arrhythmia (6020414-6)
Adverse event was reported on Dec 15, 2008 by a Female taking Dapagliflozin (Dosage: N/A) was diagnosed with
  • type 2 diabetes mellitus
and. Location: ARGENTINA , 44 years of age, Directly after, patient experienced the unwanted or unexpected Dapagliflozin side effects: ventricular arrhythmia.
Associated medications used:
  • Glipizide
  • Metformin Hcl
Patient was hospitalized.

Creatinine Renal Clearance Decreased (6013293-4)
on Dec 09, 2008 Male from ARGENTINA , 65 years of age, was diagnosed with
  • type 2 diabetes mellitus
and was treated with Dapagliflozin. Patient felt the following Dapagliflozin side effects: creatinine renal clearance decreased. Dapagliflozin dosage: 2.5 Mg Daily From 04-sep-2008; 5 Mg Daily From 25-sep-2008.

Dapagliflozin Health Episodes

Discuss Dapagliflozin Side Effects

Record and Track Your Side Effects

It is very important to keep track of all side effects and discuss them with your doctor. If you think you may have a medical emergency, call your doctor or 911 immediately.

Track Your Side Effects - It's Easy and Free. >> Start Today

Already a User? Log In

Most drugs have a large list of nonsevere or mild adverse effects which do not rule out continued usage. These effects depend on individual sensitivity, and can include nausea, dizziness, diarrhea, malaise, vomiting, headache, dermatitis, dry mouth, etc. Check commonly reported side effects . These can be considered a form of pseudo-allergic reaction, as not all users experience these effects; many users experience none at all.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Dapagliflozin Information

Did You Have a Dapagliflozin Side Effect?

Yes, Severe
Yes, Moderate
Yes, Minor
No

How Effective is Dapagliflozin for You?

Exceeded Expectations
Effective
Somewhat Effective
Not Effective